期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Medicine and Data. 2022; 6: (6) ; 179-181 ; DOI: 10.12208/j.ijmd.20220271.

Clinical effect of aspirin enteric coated tablets in the treatment of transient ischemic attack
短暂性脑缺血发作治疗中阿司匹林肠溶片临床效果观察

作者: 冯尚*,

桐柏县中心医院神经内科 河南南阳

*通讯作者: 冯尚,单位:桐柏县中心医院神经内科 河南南阳;

发布时间: 2022-11-21 总浏览量: 32

摘要

目的 对临床短暂性脑缺血发作治疗中阿司匹林肠溶片的应用效果进行探讨。方法 以我院2020年3月至2022年3月间收治的90例短暂性脑缺血发作患者为研究对象,根据治疗方案将两组均分为对照组(n=45)及观察组(n=45),对照组患者在治疗中使用的是氯吡格雷进行干预,而观察组治疗中使用的是阿司匹林肠溶片。对两组患者治疗前后凝血酶活化时间(APTT)、血浆纤维蛋白原(FIB)、凝血酶原时间(PT)、血小板计数(PLT)以及整体治疗有效率进行对比。结果 两组患者在治疗前各项指标无明显差异,P>0.05。经药物治疗干预后,两种患者血小板计数无明显差异,P>0.05。观察组患者血浆纤维蛋白原明显低于对照组,凝血酶活化时间、凝血酶原时间方面,观察组患者明显长于对照组,差异显著,P<0.05。两组患者在整体治疗有效率方面相比较。观察组患者明显更优。差异显著,P<0.05。结论 在临床治疗短暂性脑缺血发作的过程中阿司匹林肠溶片具有更加明显的治疗效果,经营药物干预后患者凝血功能指标可以得到积极改善,具有极大临床推广价值。

关键词: 短暂性脑缺血发作;阿司匹林肠溶片;临床疗效

Abstract

Objective To investigate the effect of aspirin enteric coated tablets in the treatment of transient ischemic attack (TIA).
Methods 90 patients with transient ischemic attack admitted in our hospital from March 2020 to March 2022 were taken as the research object. According to the treatment plan, the two groups were divided into the control group (n=45) and the observation group (n=45). The patients in the control group used clopidogrel for intervention in the treatment, while the patients in the observation group used aspirin enteric coated tablets in the treatment. Thrombin activation time (APTT), plasma fibrinogen (FIB), prothrombin time (PT), platelet count (PLT) and the overall treatment effectiveness were compared between the two groups before and after treatment.
Results There was no significant difference between the two groups before treatment (P>0.05). After the intervention of drug therapy, there was no significant difference in platelet count between the two patients (P>0.05). The plasma fibrinogen of patients in the observation group was significantly lower than that of the control group. In terms of thrombin activation time and prothrombin time, patients in the observation group were significantly longer than those in the control group, with significant difference (P<0.05). The two groups were compared in terms of overall treatment efficiency. The patients in the observation group were significantly better. The difference was significant (P<0.05).
Conclusion   Aspirin Rongchuang Tablet has a more obvious therapeutic effect in the clinical treatment of transient ischemic attack. After drug intervention, patients' coagulation function indicators can be actively improved, which has great clinical promotion value.

Key words: transient ischemic attack; Aspirin enteric coated tablets; Clinical efficacy

参考文献 References

[1] 于淼,陈卫,孙杨,李彬,牛昱光.血清sTREM1联合ABCD-3I评分对短暂性脑缺血发作患者近期缺血性脑卒中的预测价值分析[J].天津医药,2022,50(11):1201-1204.

[2] 高蓓,刘菲,薛金娥,赵海红.短暂性脑缺血发作患者血清RBP4、NF-κB表达与颈动脉斑块稳定性的关系[J].海南医学,2022,33(20):2599-2602.

[3] 周忠凯,石莹,钟镝,任艺博,孙佳莉,陈悦,邹文轩,隋莹,王巍.短暂性脑缺血发作患者的高分辨力MRI特征及其与ABCD3评分相关性的研究[J].磁共振成像,2022,13(10):91-97.

[4] 李丽平,赵婷.灯盏花素联合氯吡格雷治疗短暂性脑缺血发作的效果及对患者血清Ang-Ⅱ、Lp-PLA_2水平的影响[J].临床医学工程,2022,29(10):1353-1354.

[5] 陈涛,刘存国.短暂性脑缺血发作患者IVIM参数变化及其对预后的评估价值分析[J].检验医学与临床,2022,19(19):2605-2608.

[6] 李高尚.尼莫地平联合氢氯吡格雷治疗短暂性脑缺血发作的疗效评价[J].包头医学,2022,46(03):1-2.

引用本文

冯尚, 短暂性脑缺血发作治疗中阿司匹林肠溶片临床效果观察[J]. 国际医学与数据杂志, 2022; 6: (6) : 179-181.